Back

Substantial role of rare inherited variation in individuals with developmental disorders

Samocha, K. E.; Chundru, V. K.; Fu, J. M.; Gardner, E. J.; Danecek, P.; Wigdor, E. M.; Malawsky, D. S.; Lindsay, S. J.; Campbell, P.; Singh, T.; Eberhardt, R. Y.; Gallone, G.; Wright, C. F.; Martin, H. C.; Firth, H. V.; Hurles, M. E.

2024-08-29 genetic and genomic medicine
10.1101/2024.08.28.24312746 medRxiv
Show abstract

While the role of de novo and recessively-inherited coding variation in risk for rare developmental disorders (DDs) has been well established, the contribution of damaging variation dominantly-inherited from parents is less explored. Here, we investigated the contribution of rare coding variants to DDs by analyzing 13,452 individuals with DDs, 18,613 of their family members, and 3,943 controls using a combination of family-based and case/control analyses. In line with previous studies of other neuropsychiatric traits, we found a significant burden of rare (allele frequency < 1x10-5) predicted loss-of-function (pLoF) and damaging missense variants, the vast majority of which are inherited from apparently unaffected parents. These predominantly inherited burdens are strongest in DD-associated genes or those intolerant of pLoF variation in the general population, however we estimate that [~]10% of the excess of these variants in DD cases is found within the DD-associated genes, implying many more risk loci are yet to be identified. We found similar, but attenuated, burdens when comparing the unaffected parents of individuals with DDs to controls, indicating that parents have elevated risk of DDs due to these rare variants, which are overtransmitted to their affected children. We estimate that 6-8.5% of the population attributable risk for DDs are due to rare pLoF variants in those genes intolerant of pLoF variation in the general population. Finally, we apply a Bayesian framework to combine evidence from these analyses of rare, mostly-inherited variants with prior de novo mutation burden analyses to highlight an additional 25 candidate DD- associated genes for further follow up.

Matching journals

The top 1 journal accounts for 50% of the predicted probability mass.

1
The American Journal of Human Genetics
206 papers in training set
Top 0.1%
52.7%
50% of probability mass above
2
Nature Genetics
240 papers in training set
Top 1%
6.9%
3
Brain
154 papers in training set
Top 0.9%
6.4%
4
Nature Communications
4913 papers in training set
Top 39%
3.6%
5
Cell Genomics
162 papers in training set
Top 1%
3.6%
6
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 23%
3.1%
7
Human Genetics and Genomics Advances
70 papers in training set
Top 0.2%
1.9%
8
Nature Neuroscience
216 papers in training set
Top 4%
1.7%
9
Genetics in Medicine
69 papers in training set
Top 0.6%
1.7%
10
Genome Medicine
154 papers in training set
Top 5%
1.3%
11
Human Molecular Genetics
130 papers in training set
Top 2%
1.3%
12
eLife
5422 papers in training set
Top 49%
1.2%
13
Molecular Psychiatry
242 papers in training set
Top 2%
1.2%
14
PLOS Genetics
756 papers in training set
Top 14%
0.8%
15
Nature Human Behaviour
85 papers in training set
Top 4%
0.8%
16
Neuron
282 papers in training set
Top 8%
0.8%
17
npj Genomic Medicine
33 papers in training set
Top 1%
0.7%
18
JAMA Pediatrics
10 papers in training set
Top 0.3%
0.5%
19
Journal of Medical Genetics
28 papers in training set
Top 0.7%
0.5%
20
Scientific Reports
3102 papers in training set
Top 80%
0.5%
21
Cell Reports Medicine
140 papers in training set
Top 10%
0.5%
22
Nature
575 papers in training set
Top 18%
0.5%
23
Translational Psychiatry
219 papers in training set
Top 5%
0.5%
24
American Journal of Psychiatry
20 papers in training set
Top 0.6%
0.5%